The Pulmonary Function Testing Systems Market: Breathing New Life into Respiratory Care
The following diagnose or help monitor respiratory diseases during Pulmonary function testing or PFTs: These evaluate how well or badly the lung's functioning is, including asthma and chronic obstructive pulmonary disease to include pulmonary fibrosis. Market Overview The pulmonary function testing systems market is growing at a high rate due to increased respiratory diseases and technological developments in healthcare. The size of the pulmonary function testing systems market is predicted to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is anticipated to grow at a CAGR of 6.6% during 2022 to 2028. KEY MARKET DRIVERS Some of the factors driving the growth of this market are •Respiratory diseases are increasing in prevalence. This is brought about by increases of chronic respiratory diseases such as asthma, COPD, and lung cancer. •Older people have a higher predisposition to conditions involving the resp...